The funding round was led by SBI Investment alongside Sony Innovation Fund by IGV and existing backers.
"The market’s appetite for open payments accelerated dramatically last year as more merchants and payment providers have tuned into the cost and efficiency gains that they offer,"
Insurtech Gateway led the pre-seed round for the B2B insurance platform, with backing from True Sight Partners and angel investors.
"The gulf between corporates and independent retailers trying to secure credit terms is vast and, in our opinion, unfair. Our vision at BondAval is to redress this balance, allowing independent retailers to leverage investment grade security. Their word – our bond. To achieve this vision, we are excited to partner with our new investor shareholders, led by Insurtech Gateway.. They understand the value we can bring by applying digital first propositions to the world of B2B insurance."
The round was led by Initialized Capital to support expansion of the company product and engineering teams.
"We’re really excited to be partnering with Stacker. There’s a lot of buzz in the no-code space right now, but very few of these products are actually used in real businesses.What’s so compelling about Stacker is that they’ve worked out how to let people with no technical experience actually create software that helps them in their work."
The Warwickshire medical technology manufacturer has raised £250k in debt financing through the Midlands Engine Investment Fund.
"Health statistics tell us around 12 million women in North America and Europe start out trying to conceive each year. Of these, 4 million end up trying to conceive for 6 months or more, with a further 2 million moving on each year into the clinical segment. Securing additional funding is a significant step towards continuing to support women and their partners through a highly emotional journey. We would like to extend our thanks to Paul, at the FSE Group, for taking us through the process of securing finance from CBILS and MEIF – enabling us to help the business to navigate the impact of COVID-19 which will help us through these difficult times, maintaining key staff whilst continuing with key research to help us develop our product offering."